Caas Capital Management LP Pfizer Inc Transaction History

Caas Capital Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$26.13 - $33.94 $101,907 - $132,366	3,900 New	3,900 $112,000
Q2 2022 Aug 15, 2022	BUY	$46.53 - $55.17 $879,417 - $1.04 Million	18,900 New	18,900 $991,000
Q3 2021 Nov 15, 2021	SELL	$39.25 - $50.42 $726,125 - $932,770	-18,500 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$35.91 - $40.68 $585,333 - $663,084	16,300 Added 740.91%	18,500 $724,000
Q2 2020 Aug 14, 2020	BUY	$30.12 - $36.54 $66,264 - $80,388	2,200 New	2,200 $72,000

3,220

3.71B

73.2M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $163B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Caas Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Caas Capital Management LP with notifications on news.